JP2023539368A5 - - Google Patents

Info

Publication number
JP2023539368A5
JP2023539368A5 JP2023514414A JP2023514414A JP2023539368A5 JP 2023539368 A5 JP2023539368 A5 JP 2023539368A5 JP 2023514414 A JP2023514414 A JP 2023514414A JP 2023514414 A JP2023514414 A JP 2023514414A JP 2023539368 A5 JP2023539368 A5 JP 2023539368A5
Authority
JP
Japan
Prior art keywords
nucleotide sequence
seq
sequence
nucleic acid
vector
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023514414A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023539368A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/048267 external-priority patent/WO2022051232A1/en
Publication of JP2023539368A publication Critical patent/JP2023539368A/ja
Publication of JP2023539368A5 publication Critical patent/JP2023539368A5/ja
Pending legal-status Critical Current

Links

JP2023514414A 2020-09-02 2021-08-30 コドン最適化したrpgrorf15遺伝子およびその使用 Pending JP2023539368A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063073843P 2020-09-02 2020-09-02
US63/073,843 2020-09-02
PCT/US2021/048267 WO2022051232A1 (en) 2020-09-02 2021-08-30 Codon optimized rpgrorf 15 genes and uses thereof

Publications (2)

Publication Number Publication Date
JP2023539368A JP2023539368A (ja) 2023-09-13
JP2023539368A5 true JP2023539368A5 (cg-RX-API-DMAC7.html) 2024-09-06

Family

ID=80358240

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023514414A Pending JP2023539368A (ja) 2020-09-02 2021-08-30 コドン最適化したrpgrorf15遺伝子およびその使用

Country Status (10)

Country Link
US (3) US20230340042A1 (cg-RX-API-DMAC7.html)
EP (1) EP4208156A4 (cg-RX-API-DMAC7.html)
JP (1) JP2023539368A (cg-RX-API-DMAC7.html)
KR (1) KR102825852B1 (cg-RX-API-DMAC7.html)
CN (1) CN116782886A (cg-RX-API-DMAC7.html)
AU (1) AU2021337530B2 (cg-RX-API-DMAC7.html)
BR (1) BR112023003834A2 (cg-RX-API-DMAC7.html)
CA (1) CA3191540A1 (cg-RX-API-DMAC7.html)
IL (1) IL300785B2 (cg-RX-API-DMAC7.html)
WO (1) WO2022051232A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3191540A1 (en) * 2020-09-02 2022-03-10 4D Molecular Therapeutics Inc. Codon optimized rpgrorf 15 genes and uses thereof
CN117165596A (zh) * 2022-05-27 2023-12-05 武汉纽福斯生物科技有限公司 编码rpgr的核酸及其应用
CN121263322A (zh) 2023-05-11 2026-01-02 株式会社Lg新能源 用于提供与自主驾驶相关的能量管理服务的计算系统、计算系统的操作方法及车辆
AU2024315073A1 (en) * 2023-07-28 2026-01-22 Regeneron Pharmaceuticals, Inc. Use of bgh-sv40l tandem polya to enhance transgene expression during unidirectional gene insertion

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002326961A1 (en) * 2001-10-10 2003-04-22 Centocor, Inc. Nucleic acid vaccines using tumor antigen encoding nucleic acids with cytokine adjuvant encoding nucleic acid
US9163259B2 (en) * 2012-05-04 2015-10-20 Novartis Ag Viral vectors for the treatment of retinal dystrophy
CN105120901A (zh) * 2012-07-11 2015-12-02 宾夕法尼亚大学托管会 Rpgr x染色体连锁视网膜退化的aav介导的基因治疗
EP3132051B1 (en) 2014-04-15 2019-03-20 Applied Genetic Technologies Corporation Codon optimized nucleic acid encoding a retinitis pigmentosa gtpase regulator (rpgr)
GB201516066D0 (en) * 2015-09-10 2015-10-28 Young & Co Llp D Treatment of retinitis pigmentosa
WO2017197355A2 (en) * 2016-05-13 2017-11-16 4D Molecular Therapeutics Inc. Adeno-associated virus variant capsids and methods of use thereof
GB201704192D0 (en) * 2017-03-16 2017-05-03 Nightstarx Ltd Treatment of Retinitis Pigmentosa
TW202028225A (zh) 2018-09-21 2020-08-01 英商夜星克有限公司 用於治療色素性視網膜炎之組合物及方法
CN113952472A (zh) * 2020-07-21 2022-01-21 英斯培瑞有限公司 用于治疗眼部疾病的组合物和方法
CA3191540A1 (en) * 2020-09-02 2022-03-10 4D Molecular Therapeutics Inc. Codon optimized rpgrorf 15 genes and uses thereof

Similar Documents

Publication Publication Date Title
JP7860176B2 (ja) 変異aav、及び、細胞、臓器並びに組織への遺伝子導入のための組成物、方法並びに使用法
JP2021121638A5 (cg-RX-API-DMAC7.html)
JP2022125201A (ja) 変異体キャプシドを有するアデノ関連ウイルスビリオンおよびその使用方法
JP2023126919A5 (cg-RX-API-DMAC7.html)
AU2018200657B2 (en) Methods of predicting ancestral virus sequences and uses thereof
JP2024519888A5 (cg-RX-API-DMAC7.html)
AU2025271096A1 (en) A modified mGluR6 promoter and methods of use
JP2022530633A5 (cg-RX-API-DMAC7.html)
JP2022530656A5 (cg-RX-API-DMAC7.html)
JP2022544627A5 (cg-RX-API-DMAC7.html)
JP2023504773A5 (cg-RX-API-DMAC7.html)
JP2022106918A5 (cg-RX-API-DMAC7.html)
JP2023535956A5 (cg-RX-API-DMAC7.html)
RU2018142768A (ru) Варианты капсидов аденоассоциированного вируса и способы их применения
JP2019502378A5 (cg-RX-API-DMAC7.html)
US20260000721A1 (en) Means and methods for aav gene therapy in humans
JP2022522776A5 (cg-RX-API-DMAC7.html)
JP2011516049A (ja) 遺伝子障害を治療する方法
JP2023539367A5 (cg-RX-API-DMAC7.html)
JP2023513004A5 (cg-RX-API-DMAC7.html)
US20230321220A1 (en) Aav5-based vaccine against sars-cov-2
JP7627961B2 (ja) バルデー・ビードル症候群の遺伝子治療
Chen Adeno-associated virus vectors for human gene therapy
JP2022523050A5 (cg-RX-API-DMAC7.html)
CN121693341A (zh) 药物组合物及其用途